Affinity Clinical Research

Latest News and Information

Staffing Clinical Trials

The biggest expense of a research project is people.  Hiring qualified, experienced staff is not cheap.  It is, however, necessary.  Without the right people, it is unlikely the research project will make it out of the starting gates, let alone to the...

read more

Head and Neck study Now Open

We are excited to announce the Dynavax DV3-MEL-01 study for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) is now open to recruitment.  Head and Neck cancer includes cancer of the tongue, gum, mouth, salivary glands, tonsils, pharynx, nasal...

read more

Melanoma study Now Open

We are excited to announce the Dynavax DV3-MEL-01 study for metastatic or advanced melanoma is now open to recruitment (and we have already recruited our first patient!).  More information about the study can be found here. If you would to discuss this study, you can...

read more

International Clinical Trials Day 2017

Today we celebrate International Clinical Trials Day.  We would like to take this opportunity to thank all our volunteers, patients, trial participants and their families.  Without you, our wonderful researchers could not be doing the work that they do. Thank you also...

read more

International Clinical Trials Day – 20th May

On the 20th May 1747 James Lind began his trials into the cause of scurvy.  Lind's trial is recognised as one of the first clinical experiments in the history of medicine. Every year on the 20th May we pause to commemorate the work of James Lind and the countless...

read more

Happy Birthday to Us!

Today is our official first birthday and I am very excited to celebrate this milestone.  In the last twelve months, Affinity has achieved more than I could have hoped for.  Our goal at the beginning of the year was to find and initiate one study with maybe a second in...

read more

Staffing Clinical Trials

The biggest expense of a research project is people.  Hiring qualified, experienced staff is not cheap.  It is, however, necessary.  Without the right people, it is unlikely the research project will make it out of the starting gates, let alone to the...

read more

Head and Neck study Now Open

We are excited to announce the Dynavax DV3-MEL-01 study for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) is now open to recruitment.  Head and Neck cancer includes cancer of the tongue, gum, mouth, salivary glands, tonsils, pharynx, nasal...

read more

Melanoma study Now Open

We are excited to announce the Dynavax DV3-MEL-01 study for metastatic or advanced melanoma is now open to recruitment (and we have already recruited our first patient!).  More information about the study can be found here. If you would to discuss this study, you can...

read more

International Clinical Trials Day 2017

Today we celebrate International Clinical Trials Day.  We would like to take this opportunity to thank all our volunteers, patients, trial participants and their families.  Without you, our wonderful researchers could not be doing the work that they do. Thank you also...

read more

International Clinical Trials Day – 20th May

On the 20th May 1747 James Lind began his trials into the cause of scurvy.  Lind's trial is recognised as one of the first clinical experiments in the history of medicine. Every year on the 20th May we pause to commemorate the work of James Lind and the countless...

read more

Happy Birthday to Us!

Today is our official first birthday and I am very excited to celebrate this milestone.  In the last twelve months, Affinity has achieved more than I could have hoped for.  Our goal at the beginning of the year was to find and initiate one study with maybe a second in...

read more